In its role as the voice for the drug and alcohol testing industry, one of the National Drug and Alcohol Screening Association’s priorities is to provide input representing members’ interests concerning drug and alcohol testing regulations. On April 20, NDASA...
DOT
How can we help?
Featured posts
All posts
Oral Fluid Testing: Soon, But Not Yet
Since the new 2020 U.S. Department of Transportation Custody and Control Form became available in September, one tiny addition has created a tremendous amount of confusion among employers, specimen collectors and others involved in DOT-mandated drug screening. The...
NDASA Wins One for Public Safety
The National Drug & Alcohol Screening Association has had a major win today with language added to the MORE ACT that allows continued marijuana drug testing for DOT safety-sensitive workers! The MORE Act is an attempt to remove marijuana from the list of federally...
The New Normal: How to ensure compliance during COVID-19
In recent weeks, the National Drug & Alcohol Screening Association (NDASA) has hosted a series of COVID-19 Townhall Discussions for its members in the drug and alcohol screening industry. The main takeaways from these meetings? Our members are passionate...
NDASA Guidance and U.S. DOT Response to COVID-19
In light of recent reports that the Federal Motor Carriers Safety Administration (FMCSA) and other transportation modes are considering suspending random drug testing requirements during the COVID-19 health crisis, the National Drug and Alcohol Screening...
Search this site
Stay in touch
Give to NDASA
Latest News & Updates
- May 18, 2022A Sad Loss for Our Industry
- Apr 26, 2022NDASA’s Response to Proposed Guidelines for Oral Fluid Testing and Other Changes to 49 CFR Part 40
- Apr 25, 2022Start Your Engines for Conference 2022
- Mar 15, 2022Fast, Clean, Accurate Alcohol Testing – The Future is Here
- Mar 03, 2022Commit to Quality: Lessons Learned From the Search for Reliable COVID Tests
Topics We Track
- Advocacy (2)
- Committee Reports (1)
- DOT (5)
- Drug & Alcohol Testing (17)
- Drug Legislation (8)
- Feature (47)
- FMCSA (3)
- For Drug Testing Industry Professionals (14)
- For Employers and Workplace Safety & Wellness Professionals (12)
- Industry News (8)
- Marijuana & CBD (13)
- Member Benefits (1)
- Membership (2)
- NDASA Conference (8)
- NDASA Guidance (4)
- Opioids (2)
- Resources (21)
- Substance Use (1)
- Substance Use/Addiction (3)
- Training (1)
- Uncategorized (7)
- Workplace Safety (4)